JAX is a leader in neurobiology research and a resource for wherever you are in your drug discovery pipeline.
We offer the largest collection of neurological models including complex and monogenic diseases available in the world, as well as pre-clinical services featuring robust scientific expertise, numerous in life and end point measurements, phenotyping capabilities, and flexible, customizable study design for compound evaluation. We're here to answer your questions about models and relevant readouts, h and design and execute the ideal study with the goal of keeping your drug discovery journey on track.
The Jackson Laboratory Repository has focused on providing the most useful models for AD research for over a decade. These include disease models and strains useful for AD research.
Explore our collection of mouse models of Down Syndrome and other strains with chromosomal aneuploidy.
Leverage the world’s largest collections of mouse models of Huntington’s disease and more than 80 years of neurobiology research experience.
Examine mouse models of muscular dystrophy categorized by specific disease type to help you easily find the best strain for your research.
Improved animal models of Parkinsonism are essential to advance our understanding of disease pathophysiology and for eventual testing of potential therapeutics. We are currently characterizing novel models side-by-side with some of the more prominent existing mouse models of PD.
View differences between well-characterized mouse models for Rett Syndrome and find the right strain for your research.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.